AARTIDRUGS Stock View

Aarti Drugs Ltd

AARTIDRUGS Stock View

(NSE)

Trade

₹ 548.4

1.50 | 0.27

Market Cap ₹( Cr.)
50,417.15

Proj. P/E (x)
19.24

Proj. P/BV (x)
3.51

Proj. ROE (%)
20.20

Proj EV / EBITDA (x)
--

Proj. Revenue ( Cr.)
31,127.00

BUY

Last Updated On.
24-Sep-2023

 

Copy Link

Aarti Drugs Limited is an India-based company that is engaged in the manufacturing of active pharmaceutical ingredients (APIs), pharma intermediates, specialty chemicals and formulations. The Company operates through pharmaceuticals segment. The Company's APIs products include ciprofloxacin hydrochloride, metronidazole, metformin HCL, ketoconazole and ofloxacin, among others. Its specialty chemicals products include benzene sulphonyl chloride and methyl nicotinate, among others. Its pharma intermediates products include tinidazole, celecoxib, ciprofloxacin, clopidogrel, diclofenac, ketoconazole, raloxifene and zolpidem. Its products under development include itraconazole, fluconazole, dabigatran, ticagrelor, sitagliptin and alpha lipoic acid. The Company's subsidiaries include Pinnacle Life Science Private Limited, Aarti Speciality Chemicals Limited and Pinnacle Chile SPA.

Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.

Technical Data